Provided by Tiger Fintech (Singapore) Pte. Ltd.

icad

2.25
-0.0300-1.32%
Volume:113.42K
Turnover:251.65K
Market Cap:59.30M
PE:-10.56
High:2.30
Open:2.28
Low:2.19
Close:2.28
Loading ...

Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025

GlobeNewswire
·
27 Feb

iCAD, Inc. (ICAD): A Bull Case Theory

Insider Monkey
·
21 Feb

iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025

GlobeNewswire
·
19 Feb

Why iCAD Inc (ICAD) Is Skyrocketing So Far In 2025

Insider Monkey
·
04 Feb

iCAD Shares Climb After 4Q Sales Guidance Beats Expectations

Dow Jones
·
28 Jan

Why ICAD Stock Is Climbing Today

Insider Monkey
·
27 Jan

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and iCAD (ICAD)

TIPRANKS
·
27 Jan

ICAD Expects Q4 2024 Revenue Between $5.1M-$5.3M; Total Annual Recurring Revenue Reaches $9.8M, Up 11% YoY; Closed 106 Deals, Including 19 Cloud Deals

Benzinga
·
27 Jan

ICAD Pre-Announces Estimated Q4 2024 Revenue

THOMSON REUTERS
·
27 Jan

ICAD, Inc. Q4 Revenue USD 5.3 Million VS. Ibes Estimate USD 4.5 Million

THOMSON REUTERS
·
27 Jan

iCAD Pre-Announces Estimated Q4 2024 Revenue

GlobeNewswire
·
27 Jan

Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping

Insider Monkey
·
23 Jan

SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations

GlobeNewswire
·
11 Dec 2024

Corrected-(Official)-ICAD Advances Fight Against Breast Cancer With FDA-Cleared, Next-Generation AI Solutions & Profound Health Partnership (Not 'Second-Read AI' ) With Cascaid Health

THOMSON REUTERS
·
05 Dec 2024

CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024

GlobeNewswire
·
05 Dec 2024

ICAD Advances Fight Against Breast Cancer With FDA-Cleared, Next-Generation AI Solutions and a Second-Read AI Partnership With Cascaid Health at Rsna 2024

THOMSON REUTERS
·
27 Nov 2024